WORCESTER, Mass., June 17, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, provided an update on the status of the retail broker network for the Company's line of confectionary products available over-the-counter in Canada and the USA.
